Petri Pölönen

2.1k total citations
23 papers, 792 citations indexed

About

Petri Pölönen is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Petri Pölönen has authored 23 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Hematology. Recurrent topics in Petri Pölönen's work include Acute Myeloid Leukemia Research (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers) and Epigenetics and DNA Methylation (5 papers). Petri Pölönen is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers) and Epigenetics and DNA Methylation (5 papers). Petri Pölönen collaborates with scholars based in Finland, United States and Luxembourg. Petri Pölönen's co-authors include Anna–Liisa Levonen, Hanna Leinonen, Emilia Kansanen, Olli Dufva, Satu Mustjoki, Mikko Keränen, Pilvi Maliniemi, Judith Leitner, Helena Hohtari and Aleksandr Ianevski and has published in prestigious journals such as Nucleic Acids Research, Blood and Cancer Research.

In The Last Decade

Petri Pölönen

22 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petri Pölönen Finland 14 543 173 164 146 117 23 792
Andreas Janzer Germany 9 958 1.8× 196 1.1× 256 1.6× 79 0.5× 64 0.5× 17 1.1k
Stephany Corrêa Brazil 13 432 0.8× 209 1.2× 209 1.3× 50 0.3× 76 0.6× 27 670
Songfang Wu China 13 380 0.7× 64 0.4× 143 0.9× 122 0.8× 105 0.9× 15 622
Jingshan Tong United States 20 906 1.7× 410 2.4× 238 1.5× 60 0.4× 171 1.5× 32 1.3k
Aaron Nguyen United States 12 695 1.3× 207 1.2× 65 0.4× 421 2.9× 80 0.7× 21 966
Haolan Wang China 6 520 1.0× 251 1.5× 192 1.2× 61 0.4× 86 0.7× 9 861
Dan Zang China 18 486 0.9× 237 1.4× 166 1.0× 60 0.4× 68 0.6× 39 804
Fuming Zi China 15 310 0.6× 286 1.7× 156 1.0× 82 0.6× 85 0.7× 21 600
Kimie Kondo United States 15 484 0.9× 259 1.5× 127 0.8× 149 1.0× 39 0.3× 22 793
Andrea López United States 6 447 0.8× 97 0.6× 97 0.6× 134 0.9× 66 0.6× 10 607

Countries citing papers authored by Petri Pölönen

Since Specialization
Citations

This map shows the geographic impact of Petri Pölönen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petri Pölönen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petri Pölönen more than expected).

Fields of papers citing papers by Petri Pölönen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petri Pölönen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petri Pölönen. The network helps show where Petri Pölönen may publish in the future.

Co-authorship network of co-authors of Petri Pölönen

This figure shows the co-authorship network connecting the top 25 collaborators of Petri Pölönen. A scholar is included among the top collaborators of Petri Pölönen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petri Pölönen. Petri Pölönen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pölönen, Petri, et al.. (2025). Relapsed childhood T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma. Haematologica. 110(9). 1934–1950. 3 indexed citations
2.
Pölönen, Petri, Shaohua Lei, Qingsong Gao, et al.. (2025). Tallforest: Multi-omic classifier for T-lineage acute lymphoblastic leukemia. Blood. 146(Supplement 1). 336–336.
3.
Malyukova, Alena, Petri Pölönen, Juha Mehtonen, et al.. (2024). Sequential drug treatment targeting cell cycle and cell fate regulatory programs blocks non-genetic cancer evolution in acute lymphoblastic leukemia. Genome biology. 25(1). 143–143. 5 indexed citations
4.
Pölönen, Petri, Charles G. Mullighan, & David T. Teachey. (2024). Classification and risk stratification in T-lineage acute lymphoblastic leukemia. Blood. 145(14). 1464–1474. 6 indexed citations
5.
Ryan, Sarra, John F. Peden, Zoya Kingsbury, et al.. (2023). Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia. Leukemia. 37(3). 518–528. 41 indexed citations
6.
Pölönen, Petri, et al.. (2023). Computational textural mapping harmonises sampling variation and reveals multidimensional histopathological fingerprints. British Journal of Cancer. 129(4). 683–695. 1 indexed citations
7.
Härkönen, Jouni, Petri Pölönen, Ashik Jawahar Deen, et al.. (2023). A pan-cancer analysis shows immunoevasive characteristics in NRF2 hyperactive squamous malignancies. Redox Biology. 61. 102644–102644. 31 indexed citations
8.
Pölönen, Petri, et al.. (2021). Genome-wide analysis of primary microRNA expression using H3K36me3 ChIP-seq data. Computational and Structural Biotechnology Journal. 19. 1944–1955. 3 indexed citations
9.
Bouvy‐Liivrand, Maria, Kadri Õunap, Tiit Örd, et al.. (2021). Profiling of Primary and Mature miRNA Expression in Atherosclerosis-Associated Cell Types. Arteriosclerosis Thrombosis and Vascular Biology. 41(7). 2149–2167. 17 indexed citations
10.
Pölönen, Petri, Juha Mehtonen, Jake Lin, et al.. (2019). Hemap: An Interactive Online Resource for Characterizing Molecular Phenotypes across Hematologic Malignancies. Cancer Research. 79(10). 2466–2479. 19 indexed citations
11.
Dufva, Olli, Pilvi Maliniemi, Aleksandr Ianevski, et al.. (2019). Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity. Blood. 135(9). 597–609. 157 indexed citations
12.
Pölönen, Petri, Ashik Jawahar Deen, Hanna Leinonen, et al.. (2019). Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastoma. Oncogene. 38(50). 7473–7490. 66 indexed citations
13.
Sallinen, Hanna, Sirpa Janhonen, Petri Pölönen, et al.. (2019). Comparative transcriptome analysis of matched primary and distant metastatic ovarian carcinoma. BMC Cancer. 19(1). 1121–1121. 18 indexed citations
14.
Kuusanmäki, Heikki, Aino‐Maija Leppä, Petri Pölönen, et al.. (2019). Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia. Haematologica. 105(3). 708–720. 106 indexed citations
15.
Dufva, Olli, Khalid Saeed, Sara Gandolfi, et al.. (2019). CRISPR Screens Identify Mechanisms of Natural Killer Cell Evasion across Blood Cancers. Blood. 134(Supplement_1). 3597–3597. 3 indexed citations
16.
Bouvy‐Liivrand, Maria, Petri Pölönen, Juha Mehtonen, et al.. (2017). Analysis of primary microRNA loci from nascent transcriptomes reveals regulatory domains governed by chromatin architecture. Nucleic Acids Research. 45(17). 9837–9849. 35 indexed citations
17.
Linna-Kuosmanen, Suvi, Tuomo Laitinen, Mikael Peräkylä, et al.. (2016). The Effects of Sequence Variation on Genome-wide NRF2 Binding—New Target Genes and Regulatory SNPs. Nucleic Acids Research. 44(4). 1760–1775. 32 indexed citations
18.
Dufva, Olli, Petri Pölönen, Mikko Keränen, et al.. (2016). Pan-Hematopoietic Cancer Gene Expression Analysis Identifies Immunologically Active Acute Myeloid Leukemia Subtypes. Blood. 128(22). 1725–1725. 1 indexed citations
19.
Leinonen, Hanna, et al.. (2015). Dysregulation of the Keap1–Nrf2 pathway in cancer. Biochemical Society Transactions. 43(4). 645–649. 72 indexed citations
20.
Leinonen, Hanna, et al.. (2014). Role of the Keap1–Nrf2 Pathway in Cancer. Advances in cancer research. 122. 281–320. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas Janzer Breakdown of academic impact, for papers by Stephany Corrêa Breakdown of academic impact, for papers by Songfang Wu Breakdown of academic impact, for papers by Jingshan Tong Breakdown of academic impact, for papers by Aaron Nguyen Breakdown of academic impact, for papers by Haolan Wang Breakdown of academic impact, for papers by Dan Zang Breakdown of academic impact, for papers by Fuming Zi Breakdown of academic impact, for papers by Kimie Kondo Breakdown of academic impact, for papers by Andrea López
Rankless by CCL
2026